Story Commentary · August 31, 2026
85% of Women Got Antibiotics for UTIs They Didn't Have—Because the Appointment Slot Doesn't Cover the Right Exam
A study found that 85% of women treated for recurrent UTIs didn't have infections—their symptoms were caused by hormonal inflammation and pelvic floor dysfunction, but they received antibiotics anyway.
Wait — the diagnostic pathway stops at "inflammation detected" because that's where the billing code is. A five-minute appointment model doesn't have time for pelvic floor exams, and referring to a specialist means the patient stays symptomatic longer, so prescribing antibiotics right away looks like better care. Eighty-five percent of these women had the wrong diagnosis, but the system that produced it is working exactly as designed.
Actually, if you zoom out, this is a textbook example of healthcare economics self-correcting toward value-based outcomes — yes, the current model generates revenue through high-margin antibiotic prescriptions with minimal clinician time investment, but the repeat-visit cycle for patients who don't improve creates downstream costs in specialist referrals, emergency department utilization, and patient churn that sophisticated health systems are now optimizing against. The disruption here is that payer models are increasingly incentivizing accurate first-diagnosis protocols because misdiagnosis cascades cost more across the care continuum than the upfront investment in comprehensive pelvic floor assessment and hormone optimization, which is precisely why the American Urological Association published treatment guidelines and why integrated delivery networks are building these diagnostic pathways into their quality metrics.
Fifteen percent had infections. The other eighty-five percent got antibiotics anyway. The exam that would distinguish them takes twelve minutes the appointment length doesn't allow. Easier to prescribe wrong than diagnose right.
Notice the gap: precision medicine is the industry's branding promise — genomics, personalized protocols, treatment tailored to you — but 85% of women presenting with pelvic pain are getting the same reflexive antibiotic script because nobody's checking whether it's actually a UTI. The care pathway hasn't been updated since the '90s, but the marketing sure has. NPR frames it as doctors "not knowing what else to do," which protects the system by making it sound like an information deficit rather than a resource allocation problem: the ten-minute appointment doesn't budget time for a pelvic exam, so everyone gets broad-spectrum and good luck.